Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. Its
incidence cannot be measured exactly, since there are few population-based studies, but …

Background The epidemiology of mucormycosis in the era of modern diagnostics is
relatively under-explored. Objectives To examine the contemporary epidemiology, clinical …

The diagnosis and treatment of mucormycosis are challenging. The incidence of the disease
seems to be increasing. Hematological malignancies are the most common underlying …

Mucormycosis due to Mucorales is reported at large numbers in uncontrolled diabetics
across India, but systematic multicenter epidemiological study has not been published yet …

The European Conference on Infections in Leukemia (ECIL) provides recommendations for
diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various …

An increasing number of critically ill patients are immunocompromised. Acute hypoxemic
respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU …

Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Background Early diagnosis and prompt initiation of specific antifungal treatment are
essential for improving the prognosis of mucormycosis. We aimed to assess the …

Summary COVID-19-associated pulmonary mucormycosis (CAPM) remains an
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …